Literature DB >> 25698303

The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.

Feizhou Du1, Rui Jiang, Ming Gu, Ci He, Jing Guan.   

Abstract

PURPOSE: To evaluate the clinical value of 320-detector row CT in transcatheter arterial chemoembolization (TACE) treatment for hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Sixty-four patients with HCC underwent CT perfusion scanning with a 320-detector row CT before and after TACE. With the help of built-in dual-source CT perfusion software, color perfusion images of hepatic arterial perfusion (HAP), portal vein perfusion (PVP) and hepatic arterial perfusion index (HAPI) of all HCC lesions were obtained, and the above perfusion parameters were measured on the color images. The parameters obtained after TACE were compared with those obtained before TACE, and the differences were statistically analyzed.
RESULTS: There were significant differences in HAP, PVP and HAPI between cancer tissues and non-cancerous tissues before TACE (P < 0.05). HCC necrotic tissues had no blood perfusion after TACE. Lower HAP and HAPI and higher PVP were observed in active cancer tissues after operation as compared with those before operation.
CONCLUSIONS: The 320-row CT upper abdominal one-stop examination can display the whole liver perfusion well, especially the abnormal perfusion of HCC tissues and postoperative active tissues. Angiography can display the hepatic and nutrient arteries of tumors from three dimensions, and has important guiding significance in preoperative evaluation and postoperative follow up of TACE.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25698303     DOI: 10.1007/s11547-015-0523-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  20 in total

1.  Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Hiroyuki Morisaka; Katsuhiro Sano; Tsutomu Araki
Journal:  Eur J Radiol       Date:  2012-01-05       Impact factor: 3.528

2.  Capability of abdominal 320-detector row CT for small vasculature assessment compared with that of 64-detector row CT.

Authors:  Kazuhiro Kitajima; Tetsuo Maeda; Yoshiharu Ohno; Takeshi Yoshikawa; Minoru Konishi; Tomonori Kanda; Yumiko Onishi; Keiko Matsumoto; Hisanobu Koyama; Daisuke Takenaka; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2010-06-25       Impact factor: 3.528

3.  Dynamic CT angiography and CT perfusion employing a 320-detector row CT: protocol and current clinical applications.

Authors:  Eric J Salomon; Joe Barfett; Peter W A Willems; Sasikhan Geibprasert; Susanna Bacigaluppi; Timo Krings
Journal:  Klin Neuroradiol       Date:  2009-08-23

Review 4.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography.

Authors:  Michael L Steigner; Hansel J Otero; Tianxi Cai; Dimitrios Mitsouras; Leelakrishna Nallamshetty; Amanda G Whitmore; Hale Ersoy; Noah A Levit; Marcelo F Di Carli; Frank J Rybicki
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-29       Impact factor: 2.357

6.  Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.

Authors:  Davide Ippolito; Sandro Sironi; Massimo Pozzi; Laura Antolini; Laura Ratti; Chiara Alberzoni; Eugenio Biagio Leone; Franca Meloni; Maria Grazia Valsecchi; Ferruccio Fazio
Journal:  Acad Radiol       Date:  2008-07       Impact factor: 3.173

7.  320-slice CT neuroimaging: initial clinical experience and image quality evaluation.

Authors:  E Siebert; G Bohner; M Dewey; F Masuhr; K T Hoffmann; J Mews; F Engelken; H C Bauknecht; S Diekmann; R Klingebiel
Journal:  Br J Radiol       Date:  2009-02-16       Impact factor: 3.039

8.  Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

Authors:  Alejandro Forner; Carmen Ayuso; María Varela; Jordi Rimola; Amelia J Hessheimer; Carlos Rodriguez de Lope; María Reig; Luís Bianchi; Josep M Llovet; Jordi Bruix
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

9.  Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

Authors:  Andrew X Zhu; Nagaraj S Holalkere; Alona Muzikansky; Kerry Horgan; Dushyant V Sahani
Journal:  Oncologist       Date:  2008-02

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  2 in total

1.  Assessment of the embolization effect of temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogels in the rabbit renal artery by CT perfusion and confirmed by macroscopic examination.

Authors:  Zhen Zhang; Chunyuan Cen; Kun Qian; Han Li; Xin Zhang; Hongsen Zhang; Guina Ma; Yan Chen; Nanchuan Jiang; Chuansheng Zheng; Yanbing Zhao; Ping Han
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

Review 2.  A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer.

Authors:  Nunzia Garbino; Valentina Brancato; Marco Salvatore; Carlo Cavaliere
Journal:  Dose Response       Date:  2021-11-24       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.